Ramat Hovav Founded in 1987, Chemagis develops, manufactures and markets Active Pharmaceutical Ingredients (API) and Finished Dosage Forms (FDF) for generic and branded pharmaceutical companies in more than 25 countries. Chemagis' main production plant is in the Ramat Hovav Industrial Zone in the Negev Desert, about 13 kilometers (eight miles) from Beer Sheva. The unit's 300 employees in Israel work in Yad Eliyahu, Ramat Hovav and Bnei Brak. Chemagis also has subsidiaries outside Israel in India and the U.S. Chemagis employees possess great strength in complex chemistry, patents and in-depth regulatory expertise and use this expertise to offer tailor-made solutions to meet the individual requirements of customers. Chemagis holds 25 proprietary patents and has filed for 50 more. Key products include Pentoxifylline, Tramadol, Midazolam, Moxonidine, Fluticasone and Cetirizine. The unit has full current Good Manufacturing Practices (cGMP) production, from grams to multi-ton, and is fully compliant with the regulatory requirements of leading health authorities including U.S. Food and Drug Administration (FDA), U.K.'s Medicines Control Agency, Australia's Therapeutic Goods Administration, and Canada's Health Protection Branch.